In solid cancers, invasion and metastasis account for more than 90% of mortality. However, in the current armory of anticancer therapies, a specific category of anti-invasion and antimetastatic drugs is missing. Here, we coin the term ‘migrastatics’ for drugs interfering with all modes of cancer cell invasion and metastasis, to distinguish this class from conventional cytostatic drugs, which are mainly directed against cell proliferation. We define actin polymerization and contractility as target mechanisms for migrastatics, and review candidate migrastatic drugs. Critical assessment of these antimetastatic agents is warranted, because they may define new options for the treatment of solid cancers.
Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
Aneta Gandalovičová,Daniel Rosel,Michael Fernandes,P. Veselý,P. Heneberg,V. Čermák,L. Petruželka,Sunil Kumar,V. Sanz-Moreno,J. Brábek
Published 2017 in Trends in Cancer
ABSTRACT
PUBLICATION RECORD
- Publication year
2017
- Venue
Trends in Cancer
- Publication date
2017-06-01
- Fields of study
Biology, Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.